Trinity Biotech Plc - ADR
TRIB
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.48M
Close$
$-0.55
106.5% downside
Current Fair Value
106.5% downsideOvervalued by 106.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.48 Million |
|---|---|
| Enterprise Value | $136.33 Million |
| Dividend Yield | $1.10 (-) |
| Earnings per Share | $-2 |
| Beta | 1 |
| Outstanding Shares | 18,627,618 |
Return
| Return on Equity | 51.99% |
|---|---|
| Return on Assets | -35.58% |
| Return on Invested Capital | 38.28% |
Valuation & Multiples
| P/E Ratio | -0.17 |
|---|---|
| PEG | -5.55 |
| Price to Sales | 4.22 |
| Price to Book Ratio | -2.11 |
| Enterprise Value to Revenue | 3.11 |
| Enterprise Value to EBIT | -9.88 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 1.01 |
| Debt to Equity | -1.92 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 16, 2026
EPS Estimate
$-0.31
Average shareholder expectationRevenue Estimate
$10.68 M
Average shareholder expectationNext Earnings Call
Expected Date
September 3, 2026
EPS Estimate
$-0.26
Average shareholder expectationRevenue Estimate
$10.31 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.90%▼ 4.86% |
|---|---|
| Total Invested | $64,352▼ 89.07% |
| Investors Holding | 4▼ 21.00% |
ESG Score
No data